 | • レポートコード：TPM-C02115 • 出版社/出版日：Transparency Market Research / 2018年11月21日 • レポート形態：英文、PDF、208ページ • 納品方法：Eメール • 産業分類：Pharmaceutical |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、ウイルスクリアランスサービスの世界市場について調べ、ウイルスクリアランスサービスの世界規模、市場動向、市場環境、用途別（組換えタンパク質、組織及び血液由来製品、ワクチン）分析、方法別（ウイルス除去、ウイルス不活化）分析、エンドユーザー別（バイオ医薬品、受託研究機関、学術研究機関）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・ウイルスクリアランスサービスの世界市場動向 ・ウイルスクリアランスサービスの世界市場環境 ・ウイルスクリアランスサービスの世界市場規模 ・ウイルスクリアランスサービスの世界市場規模：用途別（組換えタンパク質、組織及び血液由来製品、ワクチン） ・ウイルスクリアランスサービスの世界市場規模：方法別（ウイルス除去、ウイルス不活化） ・ウイルスクリアランスサービスの世界市場規模：エンドユーザー別（バイオ医薬品、受託研究機関、学術研究機関） ・ウイルスクリアランスサービスの世界市場：地域別市場規模・分析 ・ウイルスクリアランスサービスの北米市場規模・予測 ・ウイルスクリアランスサービスのアメリカ市場規模・予測 ・ウイルスクリアランスサービスの中南米市場規模・予測 ・ウイルスクリアランスサービスのヨーロッパ市場規模・予測 ・ウイルスクリアランスサービスのアジア市場規模・予測 ・ウイルスクリアランスサービスの日本市場規模・予測 ・ウイルスクリアランスサービスの中国市場規模・予測 ・ウイルスクリアランスサービスのインド市場規模・予測 ・ウイルスクリアランスサービスの中東市場規模・予測 ・ウイルスクリアランスサービスのアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Viral Clearance Service Market: Overview
This report on the global viral clearance service market comprises an elaborate executive summary, including a market snapshot that provides information about various segments of the market. The report also provides information and data analysis of the global market with respect to its segments based on application, method, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises competitive matrix and company profiles with business overview to project the competitive landscape of the market. It also provides market attractiveness analysis in terms of geography, and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario prevailing in the global viral clearance service market.
Global Viral Clearance Service Market: Key Segments
Based on application, the global viral clearance service market has been segmented into recombinant proteins, tissue and blood derived products, vaccines, and others. In terms of method, the market has been classified into viral removal and viral inactivation. The viral inactivation segment has been further sub-segmented into chemical, radiation, and others. In terms of end-user, the market has been segregated into biopharmaceuticals, contract research organizations, academic research institutes, and other end-users. The global viral clearance service market has been analyzed based on increasing regulatory scrutiny, technology trend, expenditure on emerging technologies, and presence of key players in the region. Market size and forecast for each of these segments have been provided for the period of 2016 to 2026, along with their respective CAGR for the forecast period, i.e. from 2018 to 2026, considering 2017 as the base year.
Global Viral Clearance Service Market: Regional Outlook
In terms of region, the global viral clearance service market has been categorized into five major regions, and key countries in these regions are: North America (the U.S., Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC, South Africa, Israel, and Rest of Middle East & Africa). Market size and forecast for each of these regions and their key countries have been provided for the period of 2016 to 2026, along with their respective CAGR for the forecast period, viz. 2018-2026, considering 2017 as the base year. This report also covers the competitive scenario of the market in these regions.
Companies Mentioned in Report
The report profiles the major players operating in the global viral clearance service market in terms of attributes, such as, company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report include Texcell, Eurofins Scientific SE, Charles River Laboratories International, Inc., Merck KGaA (BioReliance), WuXi AppTec, Clean Cells, and Vironova Biosafety.
The global viral clearance service market has been segmented as follows:
Global Viral Clearance Service Market, by Application
Recombinant Proteins
Tissue and Blood Derived Products
Vaccines
Others
Global Viral Clearance Service Market, by Method
Viral Removal
Viral Inactivation
Chemical
Radiation
Other
Global Viral Clearance Service Market, by End-user
Biopharmaceuticals
Contract Research Organizations
Academic Research Institutes
Other End-users
Global Viral Clearance Service Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
Australia & New Zealand
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Israel
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Research Methodology
3. Executive Summary : Global Viral Clearance Service
3.1.Global Viral Clearance Service Market Value (US$ Mn) and Distribution, by Geography, 2017 and 2026
3.2. Global Viral Clearance Service Market Snapshot, 2017
3.3. Global Viral Clearance Service Market: Opportunity Map
4. Market Overview
4.1. Introduction
4.1.1. Application Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Increased outsourcing of viral clearance testing studies
4.3.1.2. Rise in R&D expenditure
4.3.1.3. Rise in focus on early clearance of virus in biologics
4.3.1.4. Increased burden of regulatory requirements
4.3.1.5. Technological advancements
4.3.1.6. Growing economies of the world
4.3.2. Restraints
4.3.2.1. Reduction of preclinical outsourcing budget by some of the large pharma companies
4.3.2.2. High cost and complexity involved in the development and approval of biologics and biosimilars
4.3.3. Opportunities
4.4. Global Viral Clearance Service Market Analysis and Forecast, 2016–2026
4.4.1. Global Viral Clearance Service Market Value (US$ Mn) Forecast
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Regulatory Scenario by Region/globally
5.2. Key Mergers & Acquisitions
5.3. Technological Advancements
5.4. Key Market Trends
5.5. Competitive Landscape Analysis (based on strategic developments of players)
5.6. Future Prospects Assessment
6. Global Viral Clearance Service Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Viral Clearance Service Market Value Forecast, by Application, 2016–2026
6.3.1. Recombinant Proteins
6.3.2. Tissue and Blood Derived Products
6.3.3. Vaccines
6.3.4. Others
6.4. Global Viral Clearance Service Market Attractiveness, by Application
7. Global Viral Clearance Service Analysis and Forecast, by Method
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Viral Clearance Service Market Value Forecast, by Method, 2016–2026
7.3.1. Viral Removal
7.3.2. Viral Inactivation
7.3.2.1. Chemical
7.3.2.2. Radiation
7.3.2.3. Other
7.4. Global Viral Clearance Service Market Attractiveness, by Method
8. Global Viral Clearance Service Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
8.3.1. Biopharmaceuticals
8.3.2. Contract Research Organizations
8.3.3. Academic Research Institutes
8.3.4. Other End-users
8.4. Global Viral Clearance Service Market Attractiveness by End-user
9. Global Viral Clearance Service Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Viral Clearance Service Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Viral Clearance Service Market Attractiveness, by Region
10. North America Viral Clearance Service Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Viral Clearance Service Market Value Forecast, by Application, 2016–2026
10.2.1. Recombinant Proteins
10.2.2. Tissue and Blood Derived Products
10.2.3. Vaccines
10.2.4. Others
10.3. North America Viral Clearance Service Market Value Forecast, by Method, 2016–2026
10.3.1. Viral Removal
10.3.2. Viral Inactivation
10.3.2.1. Chemical
10.3.2.2. Radiation
10.3.2.3. Other
10.4. North America Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
10.4.1. Biopharmaceuticals
10.4.2. Contract Research Organizations
10.4.3. Academic Research Institutes
10.4.4. Other End-users
10.5. North America Viral Clearance Service Market Value Forecast, by Country, 2016–2026
10.5.1. U.S.
10.5.2. Canada
10.6. North America Viral Clearance Service Market Attractiveness Analysis
10.6.1. By Application
10.6.2. By Method
10.6.3. By End-user
10.6.4. By Country
11. Europe Viral Clearance Service Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2. Europe Viral Clearance Service Market Value Forecast, by Application, 2016–2026
11.2.1. Recombinant Proteins
11.2.2. Tissue and Blood Derived Products
11.2.3. Vaccines
11.2.4. Others
11.3. Europe Viral Clearance Service Market Value Forecast, by Method, 2016–2026
11.3.1. Viral Removal
11.3.2. Viral Inactivation
11.3.2.1. Chemical
11.3.2.2. Radiation
11.3.2.3. Other
11.4. Europe Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
11.4.1. Biopharmaceuticals
11.4.2. Contract Research Organizations
11.4.3. Academic Research Institutes
11.4.4. Other End-users
11.5. Europe Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2016–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Viral Clearance Service Market Attractiveness Analysis
11.6.1. By Application
11.6.2. By Method
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Viral Clearance Service Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2. Asia Pacific Viral Clearance Service Market Value Forecast, by Application, 2016–2026
12.2.1. Recombinant Proteins
12.2.2. Tissue and Blood Derived Products
12.2.3. Vaccines
12.2.4. Others
12.3. Asia Pacific Viral Clearance Service Market Value Forecast, by Method, 2016–2026
12.3.1. Viral Removal
12.3.2. Viral Inactivation
12.3.2.1. Chemical
12.3.2.2. Radiation
12.3.2.3. Other
12.4. Asia Pacific Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
12.4.1. Biopharmaceuticals
12.4.2. Contract Research Organizations
12.4.3. Academic Research Institutes
12.4.4. Other End-users
12.5. Asia Pacific Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Viral Clearance Service Market Attractiveness Analysis
12.6.1. By Application
12.6.2. By Method
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Viral Clearance Service Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2. Latin America Viral Clearance Service Market Value Forecast, by Application, 2016–2026
13.2.1. Recombinant Proteins
13.2.2. Tissue and Blood Derived Products
13.2.3. Vaccines
13.2.4. Others
13.3. Latin America Viral Clearance Service Market Value Forecast, by Method, 2016–2026
13.3.1. Viral Removal
13.3.2. Viral Inactivation
13.3.2.1. Chemical
13.3.2.2. Radiation
13.3.2.3. Other
13.4. Latin America Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
13.4.1. Biopharmaceuticals
13.4.2. Contract Research Organizations
13.4.3. Academic Research Institutes
13.4.4. Other End-users
13.5. Latin America Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Viral Clearance Service Market Attractiveness Analysis
13.6.1. By Application
13.6.2. By Method
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Viral Clearance Service Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Viral Clearance Service Market Value Forecast, by Application, 2016–2026
14.2.1. Recombinant Proteins
14.2.2. Tissue and Blood Derived Products
14.2.3. Vaccines
14.2.4. Others
14.3. Middle East & Africa Viral Clearance Service Market Value Forecast, by Method, 2016–2026
14.3.1. Viral Removal
14.3.2. Viral Inactivation
14.3.2.1. Chemical
14.3.2.2. Radiation
14.3.2.3. Other
14.4. Middle East & Africa Viral Clearance Service Market Value Forecast, by End-user, 2016–2026
14.4.1. Biopharmaceuticals
14.4.2. Contract Research Organizations
14.4.3. Academic Research Institutes
14.4.4. Other End-users
14.5. Middle East & Africa Viral Clearance Service Market Value Forecast, by Country/Sub-region, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Viral Clearance Service Market Attractiveness Analysis
14.6.1. By Application
14.6.2. By Method
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Global Viral Clearance Service Market Player – Competition Matrix (by Tier and Size of companies)
15.2. Global Viral Clearance Service Market Share Analysis, by Company (2017)
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. Texcell
15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.1.2. Company Financials
15.4.1.3. Growth Strategies
15.4.1.4. Recent Events
15.4.1.5. SWOT Analysis
15.4.2. Eurofins Scientific SE
15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.2.2. Company Financials
15.4.2.3. Growth Strategies
15.4.2.4. Recent Events
15.4.2.5. SWOT Analysis
15.4.3. Charles River Laboratories International, Inc.
15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.3.2. Company Financials
15.4.3.3. Growth Strategies
15.4.3.4. Recent Events
15.4.3.5. SWOT Analysis
15.4.4. Merck KGaA (BioReliance)
15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.4.2. Company Financials
15.4.4.3. Growth Strategies
15.4.4.4. Recent Events
15.4.4.5. SWOT Analysis
15.4.5. WuXi AppTec
15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.5.2. Company Financials
15.4.5.3. Growth Strategies
15.4.5.4. Recent Events
15.4.5.5. SWOT Analysis
15.4.6. Clean Cells
15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.6.2. Company Financials
15.4.6.3. Growth Strategies
15.4.6.4. Recent Events
15.4.6.5. SWOT Analysis
15.4.7. Vironova Biosafety
15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.7.2. Company Financials
15.4.7.3. Growth Strategies
15.4.7.4. Recent Events
15.4.7.5. SWOT Analysis
Table 01: Global Viral Clearance Service Market Value (US$ Mn) Forecast, 2016–2026
Table 02: Global Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 03: Global Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
Table 04: Global Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 05: Global Viral Clearance Service Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 07: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 08: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
Table 09: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
Table 10: North America Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 12: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 13: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
Table 14: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
Table 15: Europe Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 16: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 17: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 18: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
Table 19: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
Table 20: Asia Pacific Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 21: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 23: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
Table 24: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
Table 25: Latin America Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 26: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 27: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 28: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by Method, 2016–2026
Table 29: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by Viral Inactivation, 2016–2026
Table 30: Middle East & Africa Viral Clearance Service Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 31: Competition Matrix